Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 811 AL 825

New Treatment Approach Using Peptoid-Based Vaccines in Parkinson's Disease

Ekrani ST, Faraj TA, Taha CH, Esmaeili SA.

Drug Dev Res. 2026 Jun;87(4):e70310. doi: 10.1002/ddr.70310.

Mirabegron and Intradetrusor Onabotulinumtoxina for Overactive Bladder in Parkinson's Disease: A Systematic Review and Meta-Analysis

Arshad H, Nuha R, Khashaba S, Gillatt D, Lewis SJG.

Neurourol Urodyn. 2026 Jun 2. doi: 10.1002/nau.70322. Online ahead of print.

Using Open-Window Mapping Strategy for Wolff-Parkinson-White Syndrome in a Patient With Dextrocardia With Situs Inversus

Huang DS, Wang YC, Chen YL, Po SS.

Pacing Clin Electrophysiol. 2026 Jun 2. doi: 10.1111/pace.70311. Online ahead of print.

Planimetric and Linear MRI Markers for Progressive Supranuclear Palsy Classification: A Large Multicohort International Study

Quattrone A, Bianco MG, Vescio B, Chimento I, Sacilotti A, Oliveti C, Arcuri PP, Stanà C, Tinelli E, Sabatini U, Kaasinen V, Franzmeier N, Stefanis L, Velonakis G, Boxer A, Constantinides VC, Höglinger GU, Quattrone A; PASSPORT Study Group; AL-108-231 Investigators; TAUROS MRI Investigators; DescribePSP group; AL-108-231 Study Group; Tau Restoration on PSP (TAUROS) MRI Investigators; DESCRIBE-PSP Study Group.

Radiology. 2026 Jun;319(3):e251394. doi: 10.1148/radiol.251394.

Progress of Immunotherapies in Parkinson's Disease

Peng Y, Kang XH, Yao SY, Zhang X, Kazuo S, Liu J, Du MQ, Lin LX, Jiang DY, Chen Q, Jin H.

CNS Neurosci Ther. 2026 Jun;32(6):e70964. doi: 10.1002/cns.70964.

Beyond "Advanced": proposing Fluctuation-Dominant Parkinson's disease as a functional alternative to enable timely device-aided therapy

Mittal SO, Jost WH.

J Neural Transm (Vienna). 2026 Jun 2. doi: 10.1007/s00702-026-03185-1. Online ahead of print.

Platelet-derived extracellular vesicles as neurodegenerative disease biomarkers

Alqahtani SM, Afzal M, Afzal O, Alabbas A, Phalak P, Goyal K.

Clin Chim Acta. 2026 Sep 15;591:121130. doi: 10.1016/j.cca.2026.121130. Epub 2026 Jun 1.

Polymeric lysosome-targeting chimeras for extracellular α-synuclein degradation in Parkinson's disease

Bhattacharya A, Almohaimeed HM, Aggad WS, Almars AI, Altowaijri OMA, Waggas HA, Bauthman NM, Mohammedsaleh ZM, ALMatrafi TA, Saleh FM, Uti DE.

Acta Neuropathol Commun. 2026 Jun 2;14(1):164. doi: 10.1186/s40478-026-02335-6.

Leucine-rich repeat kinase 2 (LRRK2): balancing cellular homeostasis and Parkinson's disease (PD) pathogenesis

Aolymat I, Abu-Hassan DW, Oleimat AK, Sameer W, Wreikat B, Iqilan T, Al-Momani H, Ali H, Tahtamouni L, Iqsairi M, Albeik M, Debas O.

Ann Med. 2026 Dec;58(1):2677288. doi: 10.1080/07853890.2026.2677288. Epub 2026 Jun 3.

Charting the human-specific properties of gene expression networks in the infant prefrontal cortex

Klavert J, Radjabzadeh D, Gonzalez Sanchez E, Castelijns B, Timpanaro IS, Boers J, Fabro F, Vroeg In de Wei G, Bindels E, Kondova I, Gribnau J, Creyghton MP.

Sci Adv. 2026 Jun 5;12(23):eaea3316. doi: 10.1126/sciadv.aea3316. Epub 2026 Jun 3.

Exosome mimetic nanoparticles for siRNA based targeting of α-synuclein and neuroinflammation in Parkinson's disease

Shamim S, Singh AP, Sharma H, Gohri S, Taumar D, Chaudhary V.

J Pharm Pharmacol. 2026 Jun 2;78(6):rgag052. doi: 10.1093/jpp/rgag052.

Effects of a Home-Based Exercise Program Incorporating Mindfulness and Yoga on Balance and Mobility in People With Parkinson Disease: Protocol for a Randomized Controlled Trial

Kwok JYY, Chan LML, Shum YY, Pang SYY, Auyeung M, Bloem BR.

JMIR Res Protoc. 2026 Jun 3;15:e97781. doi: 10.2196/97781.

Phytochemical engineered quantum dots as potential therapy to counter alpha synuclein aggregation in Parkinson's disease

Shashwat P, Kirthi AV, Selvaraj M, Karnwal A, Dutta J.

Neurochem Int. 2026 Sep;198:106194. doi: 10.1016/j.neuint.2026.106194. Epub 2026 Jun 2.

Long-term effect of the German Parkinson's disease multimodal complex treatment: a clinical trial with randomized allocation

Heimrich KG, Schönenberg A, Mendorf S, Mühlhammer HM, Teschner U, Lehmann T, Brodoehl S, Prell T.

BMC Neurol. 2026 Jun 4;26(1):372. doi: 10.1186/s12883-026-05039-5.

Nanotechnology for efficient delivery of TCM active ingredients in treating brain diseases

Yang Y, Gao Y, Li J, Zou J, Luan F, Shi Y, Zhai B, Huang Q.

Mater Today Bio. 2026 May 22;38:103265. doi: 10.1016/j.mtbio.2026.103265. eCollection 2026 Jun.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias